Hemispherx Biopharma CEO Thomas Equels' 2018 pay rises 19% to $1.2M
Hemispherx Biopharma reports 2018 executive compensation
By ExecPay News
Published: August 20, 2019
Hemispherx Biopharma reported fiscal year 2018 executive compensation information on August 20, 2019.
In 2018, three executives at Hemispherx Biopharma received on average a compensation package of $697K, a 24% increase compared to previous year.
Thomas K. Equels, Chief Executive Officer, received $1.2M in total, which increased by 19% compared to 2017. 64% of Equels' compensation, or $751K, was in salary. Equels also received $18K in bonus, $336K in option awards, $500 in stock awards, as well as $66K in other compensation.
Peter Rodino, General Counsel, received a compensation package of $527K, which increased by 32% compared to previous year. 67% of the compensation package, or $351K, was in salary.
Adam Pascale, Chief Financial Officer, earned $392K in 2018, a 33% increase compared to previous year.